These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 35250172)

  • 1. CRISPR/Cas12a-based technology: A powerful tool for biosensing in food safety.
    Mao Z; Chen R; Wang X; Zhou Z; Peng Y; Li S; Han D; Li S; Wang Y; Han T; Liang J; Ren S; Gao Z
    Trends Food Sci Technol; 2022 Apr; 122():211-222. PubMed ID: 35250172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a fluorescence/colorimetric biosensor based on the cleavage activity of CRISPR-Cas12a for the detection of non-nucleic acid targets.
    Wang Y; Peng Y; Li S; Han D; Ren S; Qin K; Zhou H; Han T; Gao Z
    J Hazard Mater; 2023 May; 449():131044. PubMed ID: 36821893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-point dual specific detection of nucleic acids using CRISPR/Cas12a based portable biosensor.
    Wu H; Qian C; Wu C; Wang Z; Wang D; Ye Z; Ping J; Wu J; Ji F
    Biosens Bioelectron; 2020 Jun; 157():112153. PubMed ID: 32250930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas12a Biosensor Array for Ultrasensitive Detection of Unamplified DNA with Single-Nucleotide Polymorphic Discrimination.
    Weng Z; You Z; Li H; Wu G; Song Y; Sun H; Fradlin A; Neal-Harris C; Lin M; Gao X; Zhang Y
    ACS Sens; 2023 Apr; 8(4):1489-1499. PubMed ID: 37027291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic-Acid Targets.
    Xiong Y; Zhang J; Yang Z; Mou Q; Ma Y; Xiong Y; Lu Y
    J Am Chem Soc; 2020 Jan; 142(1):207-213. PubMed ID: 31800219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in aptamer and CRISPR-Cas12a based systems for non-nucleic target detection.
    Yang R; Zhao L; Wang X; Kong W; Luan Y
    Crit Rev Anal Chem; 2024; 54(7):2670-2687. PubMed ID: 37029907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPA-Cas12a-FS: A frontline nucleic acid rapid detection system for food safety based on CRISPR-Cas12a combined with recombinase polymerase amplification.
    Liu H; Wang J; Zeng H; Liu X; Jiang W; Wang Y; Ouyang W; Tang X
    Food Chem; 2021 Jan; 334():127608. PubMed ID: 32711280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.
    Shu X; Zhang D; Li X; Zheng Q; Cai X; Ding S; Yan Y
    ACS Synth Biol; 2022 Aug; 11(8):2829-2836. PubMed ID: 35946354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas12a-Based Diagnostic Platform Accurately Detects
    Qiu X; Xu S; Liu X; Ren H; Han L; Li Z
    Front Cell Infect Microbiol; 2022; 12():884411. PubMed ID: 35719360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XNA probe and CRISPR/Cas12a-powered flexible fluorescent and electrochemical dual-mode biosensor for sensitive detection of m6A site-specific RNA modification.
    Pu Q; Ye Y; Hu J; Xie C; Zhou X; Yu H; Liao F; Jiang S; Jiang L; Xie G; Chen W
    Talanta; 2023 Jan; 252():123754. PubMed ID: 36029686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocapture Magnetic Beads Enhanced the LAMP-CRISPR/Cas12a Method for the Sensitive, Specific, and Visual Detection of
    Li C; Chen X; Wen R; Ma P; Gu K; Li C; Zhou C; Lei C; Tang Y; Wang H
    Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323424
    [No Abstract]   [Full Text] [Related]  

  • 12. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing Multiplex crRNA in the CRISPR/Cas12a System Enables an Amplification-Free DNA Diagnostic Platform for ASFV Detection.
    Zeng M; Ke Y; Zhuang Z; Qin C; Li LY; Sheng G; Li Z; Meng H; Ding X
    Anal Chem; 2022 Aug; 94(30):10805-10812. PubMed ID: 35857897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review).
    Dronina J; Samukaite-Bubniene U; Ramanavicius A
    J Nanobiotechnology; 2022 Jan; 20(1):41. PubMed ID: 35062978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas based virus detection: Recent advances and perspectives.
    Yin L; Man S; Ye S; Liu G; Ma L
    Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
    Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Pot Assay for Rapid Detection of Benzimidazole Resistance in
    Hu JJ; Liu D; Cai MZ; Zhou Y; Yin WX; Luo CX
    J Agric Food Chem; 2023 Jan; 71(3):1381-1390. PubMed ID: 36624936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR Cas12a-based "sweet" biosensor coupled with personal glucose meter readout for the point-of-care testing of Salmonella.
    Zhou C; Huang D; Wang Z; Shen P; Wang P; Xu Z
    J Food Sci; 2022 Sep; 87(9):4137-4147. PubMed ID: 35986652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas12a-based magnetic relaxation switching biosensor for nucleic acid amplification-free and ultrasensitive detection of methicillin-resistant Staphylococcus aureus.
    Wei L; Wang Z; Wu L; Chen Y
    Biosens Bioelectron; 2023 Feb; 222():114984. PubMed ID: 36493720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas12a-Powered Dual-Mode Biosensor for Ultrasensitive and Cross-validating Detection of Pathogenic Bacteria.
    Ma L; Peng L; Yin L; Liu G; Man S
    ACS Sens; 2021 Aug; 6(8):2920-2927. PubMed ID: 34281340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.